The known pathogenic variants previously identified in FOXE3 are predominantly responsible for causing aphakia, sclerocornea, microphthalmia, anterior segment dysgenesis, and, rarely, increased intraocular pressure, bilateral congenital cataract, and vitreoretinal dysplasia [24,34,36,37]. This evidence concerns the gene FOXE3 and microphthalmia.